You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nontuberculous mycobacterium

Showing 1 - 25 of 306
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nontuberculous Mycobacterium Infection, Mycobacterium Abscessus Infection Trial (Delpazolid)

Not yet recruiting
  • Nontuberculous Mycobacterium Infection
  • Mycobacterium Abscessus Infection
  • (no location specified)
Aug 21, 2023

Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection Trial in New York, Portland, Toronto

Recruiting
  • Nontuberculous Mycobacterial Lung Disease
  • Nontuberculous Mycobacterium Infection
  • Hypertonic saline
  • +3 more
  • New York, New York
  • +2 more
Jan 27, 2023

Healthcare-associated Links in Transmission of Nontuberculous

Recruiting
  • Cystic Fibrosis
  • Nontuberculous Mycobacterium Infection
  • Epidemiologic investigation
  • Denver, Colorado
    National Jewish Health
Apr 6, 2022

Transmission and Acquisition of Nontuberculous Mycobacteria

Recruiting
  • Nontuberculous Mycobacterial Pulmonary Infection
  • +3 more
  • Epidemiologic investigation
  • Denver, Colorado
    National Jewish Health
Dec 1, 2023

Mycobacterium Avium Complex Pulmonary Disease Trial (Minocycline)

Not yet recruiting
  • Mycobacterium Avium Complex Pulmonary Disease
  • (no location specified)
May 15, 2023

Nontuberculous Mycobacterium Infection Trial in United States (Gallium nitrate)

Recruiting
  • Nontuberculous Mycobacterium Infection
  • Gallium nitrate
  • Birmingham, Alabama
  • +8 more
Jan 10, 2023

Tuberculosis, Latent Tuberculosis, Nontuberculous Mycobacterium Infection Trial in Busan (therapeutic drug monitoring(TDM))

Recruiting
  • Tuberculosis
  • +2 more
  • therapeutic drug monitoring(TDM)
  • Busan, Korea, Republic of
    Inje University Busan Paik Hoapital Clinical Trial Center
Mar 6, 2022

Prospective Healthcare-Associated Links in Transmission of

Enrolling by invitation
  • Cystic Fibrosis
  • Nontuberculous Mycobacterial Pulmonary Infection
    • Denver, Colorado
      National Jewish Health
    Jan 6, 2023

    Mycobacterium Infections, Nontuberculous, Mycobacterium Abscessus Infection, Nontuberculous Mycobacterial Lung Disease Trial in

    Recruiting
    • Mycobacterium Infections, Nontuberculous
    • +3 more
    • Omadacycline Oral Tablet
    • Placebo
    • Birmingham, Alabama
    • +20 more
    Jan 11, 2023

    Mycobacterium Abscessus Infection in Chronic Lung Disease and

    Enrolling by invitation
    • Mycobacterium Abscessus Infection
    • +2 more
    • Appropriate treatment
    • Pathum Wan, Bangkok, Thailand
      King Chulalongkorn Memorial Hospital
    Aug 31, 2022

    PK and PD of Antibiotics for Treatment of Mycobacterium

    Not yet recruiting
    • Nontuberculous Mycobacterial Pulmonary Infection
    • Measuring PK and PD indices in patients who receive conventional treatment
    • (no location specified)
    Dec 22, 2022

    Mycobacterium Infections, Nontuberculous Trial in Saint Louis (Recombinant human interleukin-7)

    Recruiting
    • Mycobacterium Infections, Nontuberculous
    • Recombinant human interleukin-7
    • Saint Louis, Missouri
      Washington University
    Mar 30, 2022

    Nontuberculous Mycobacterial Diseases Trial in Nijmegen (Clofazimine)

    Recruiting
    • Nontuberculous Mycobacterial Diseases
    • Nijmegen, Gelderland, Netherlands
      Radboud university medical center
    Sep 9, 2022

    Expectorated and Induced Sputum and Pharyngeal Swabs for

    Completed
    • Myobacterium Infections, Nontuberculous
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Trial (Placebo, SPR720 500 mg, SPR720 1000 mg)

      Not yet recruiting
      • Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
      • Placebo
      • +2 more
      • (no location specified)
      Aug 9, 2022

      Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection Trial in Canada, United States (Azithromycin, Ethambutol,

      Recruiting
      • Mycobacterium Avium Complex
      • Nontuberculous Mycobacterium Infection
      • Loma Linda, California
      • +26 more
      Jan 18, 2023

      Mycobacterium Infections, Nontuberculous, Cystic Fibrosis (CF) Trial in United States (Molgramostim nebulizer solution, PARI

      Terminated
      Has Results
      • Mycobacterium Infections, Nontuberculous
      • Cystic Fibrosis (CF)
      • Molgramostim nebulizer solution
      • PARI eFlow nebulizer system
      • Denver, Colorado
      • +4 more
      Oct 10, 2021

      Nontuberculous Mycobacterium Infection Trial in Portland, Charleston (gNO)

      Completed
      Has Results
      • Nontuberculous Mycobacterium Infection
      • Portland, Oregon
      • +1 more
      May 17, 2021

      Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

      Active, not recruiting
      • Mycobacterium Infections, Nontuberculous
      • Birmingham, Alabama
      • +110 more
      Jan 23, 2023

      Mycobacterium Infections, Nontuberculous Trial in Australia, United Kingdom (Inhaled molgramostim)

      Completed
      • Mycobacterium Infections, Nontuberculous
      • Inhaled molgramostim
      • Concord, New South Wales, Australia
      • +4 more
      Mar 23, 2021

      Nontuberculous Mycobacteria in the Geneva Area (2015-2020)

      Completed
      • Ecology of Nontubercuous Mycobacteria
      • Geneva Area
        • Geneva, Switzerland
          Geneva University Hospital
        Jan 17, 2021

        Non-Tuberculous Mycobacterial Pneumonia, Cystic Fibrosis, Mycobacterial Pneumonia Trial in Greenslopes (LungFit)

        Recruiting
        • Non-Tuberculous Mycobacterial Pneumonia
        • +4 more
        • LungFit
        • Greenslopes, Queensland, Australia
          Gallipoli Medical Research Foundation
        Dec 24, 2020

        Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

        Recruiting
        • Mycobacterium Infections, Nontuberculous
        • Birmingham, Alabama
        • +172 more
        Jan 23, 2023

        Mycobacterium Infections, Nontuberculous Trial (LAI (Liposomal Amikacin for Inhalation) 590 mg)

        Completed
        Has Results
        • Mycobacterium Infections, Nontuberculous
        • LAI (Liposomal Amikacin for Inhalation) 590 mg
        • (no location specified)
        Apr 22, 2020

        Non-tuberculous Mycobacterial Infections Trial in Bangkoknoi (Oral Tablet)

        Unknown status
        • Non-tuberculous Mycobacterial Infections
        • Oral Tablet
        • Bangkoknoi, Bangkok, Thailand
          Siriraj Hospital
        Apr 17, 2020